Table 1.
Visit | Visit 0 Screening (Day −7 to −1) |
Visit 1 Enrollment and randomization (Day 1) |
Visit 2 (4 wks) | Visit 3:(8 wks) | Visit 4 (12 wks) | Visit 5:(16 wks) |
Visit 6 Intervention completion1 (24 wks) |
Visit 7: Study completion (28 wks) | |
---|---|---|---|---|---|---|---|---|---|
Informed consent | X | Interim analysis | |||||||
Demographics | X | ||||||||
Inclusion exclusion criteria | X | ||||||||
Medical history | X | ||||||||
Concomitant illness | X | X | X | X | X | X | X | ||
Randomization | X | ||||||||
Complete physical examination | X | X | X | X | X | X | X | X | |
WHO QOL BREF@ | X | X | X | X | |||||
HR-BHF# | X | X | X | X | |||||
Vital signs | X | X | X | X | X | X | X | X | |
Ayurvedic evaluation: prakriti | X | ||||||||
Ayurvedic evaluation: dhatu sarata | X | X | X | X | X | X | X | ||
Ayurvedic evaluation: | X | X | X | X | X | X | X | ||
Electrocardiogram | X | X | |||||||
Chest radiograph | X | X | |||||||
Study drug dispensation | X | X | X | X | X | ||||
Adverse event assessment | X | X | X | X | X | X | |||
Mobile App–Kavach–self reported questionnaire* | X | X | X | X | X | X | X | ||
Completion and outcome report | X |
To be completed daily by participants.
HR-BHF: Health Related-Habits, Behavior and Fitness.
WHO QOL BREF: World Health Organization Quality of Life Instruments-short form.